Panel | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
|
...
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Rules Based on Patient's Age
Series Completion Special Rule
|
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Notes
|
Meningococcal Vaccines
CVX Code | Name | Absolute Minimum Age |
---|---|---|
114 | meningococcal MCV4P (Menactra) | 9 months - 4 days |
136 | meningococcal MCV4O (Menveo) | 2 months - 4 days |
32 | meningococcal MPSV4 (Menomune) | 2 years - 4 days |
108 | meningococcal, unspecified formulation | 2 years - 4 days4 |
147 | meningococcal MCV4, unspecified formulation | 9 months - 4 days4 |
...
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Notes
|
...
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Notes
|
...
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|
1 | MCV4 2-dose | 10 years | 10 11 years | 11 years | 114, 136, 108, 147, 32 | N/A |
2 | MCV4 2-dose | 16 years - 4 days | 16 years | 16 years | 114, 136, 108, 147, 32 | N/A |
...
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Minimum Recommended Interval |
---|---|---|---|---|
Dose 1 to 2 | MCV4 2-dose | 52 days | 56 days | 56 days2 |
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Special RulesShots Administered Below Series Recommended Age for Dose 1
MCV4 2-Dose Series Exception Rule
|
...
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Notes
|